Nanny State New York City is Bad for Business
28 September 2012
Michelle Minton, Fellow in Consumer Policy Studies at the Competitive Enterprise Institute, discusses how New York City's big-soda ban will do nothing to solve obesity, further entrench the idea that New York is bad for business, and which begs the question: Who has the right to decide what you consume?
0:00 0:00

Related Podcasts

All Eyes on New York and Virginia
23 October 2025
William J. Conti, a retired attorney from Washington, DC, discusses the latest news on the upcoming mayoral election in New York City and the governor’s race in Virginia.
Good News on the Economy, Bad News on Crime
18 September 2025
Timothy Lee, CFIF's Senior Vice President of Legal and Public Affairs, discusses recent economic news and the state of the U.S. economy, as well as crime and the methods and policies that work to reduce it.
The State of the U.S. Economy
21 August 2025
Phil Kerpen, President of American Commitment, discusses the current state of the U.S. economy, the outlook for economic growth, what the future looks like for energy prices and regulation, and what impact tariffs may have on the economy.
DOGE, Regulations and the Administrative State
13 June 2025
Wayne Crews, the Fred L. Smith Fellow in Regulatory Studies at the Competitive Enterprise Institute, discusses the recently released "Ten Thousand Commandments: An Annual Snapshot of the Federal Regulatory State,” how Congress is disregarding its enumerated powers, and the role of DOGE to commence deconstruction of the administrative state.
Encouraging Healthcare Competition and Lower Costs: Antiquated State CON Laws Must Go
21 March 2025
Jaimie Cavanaugh, Legal Policy Counsel at the Pacific Legal Foundation, discusses what states can do to create more competition and drive down the rising cost of healthcare, how Certificate of Need (CON) laws impede access to care and block competition while limiting consumer choice and stifling innovation, and what state legislators can and should do to reform and repeal these antiquated laws.
Government Price Controls for Prescription Drugs Are Bad Medicine for Americans
28 June 2024
Sally Pipes, President and CEO of Pacific Research Institute, discusses how President Biden's price controls will result in prescription drug shortages and discourage innovation, how government mandates and regulations raise insurance costs, and the grim prognosis on Medicare and Medicaid's viability.